The Global CEO Initiative on Alzheimer’s Disease Launches Groundbreaking Alzheimer’s Blood Test Performance Database for Clinicians

Press ReleasesWorkgroup Activities
Written By Emily Scholler
Emily Scholler
Previous

FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
Next

CEOi Launches Three Part Podcast Series, “A Breakthrough in Alzheimer’s Diagnostics: Integrating Blood Tests into Clinical Practice” in partnership with Pri-Med